104 related articles for article (PubMed ID: 3043438)
1. Effects of PAF on neutrophils and mononuclear phagocytes.
Baggiolini M; Dewald B; Thelen M
Prog Biochem Pharmacol; 1988; 22():90-105. PubMed ID: 3043438
[No Abstract] [Full Text] [Related]
2. [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
Shebzukhov IuV; Mysiakin EB
Vopr Med Khim; 1996; 42(4):278-83. PubMed ID: 9254510
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.
Bussolati B; Mariano F; Cignetti A; Guarini A; Cambi V; Foà R; Piccoli G; Camussi G
J Immunol; 1998 Aug; 161(3):1493-500. PubMed ID: 9686616
[TBL] [Abstract][Full Text] [Related]
4. The mononuclear phagocyte system: the heart of host defense.
Blaese RM; Muchmore AV
Mead Johnson Symp Perinat Dev Med; 1986; (24):13-5. PubMed ID: 3091969
[No Abstract] [Full Text] [Related]
5. Chemotaxis and motility of lung phagocytes.
Nelson RD; Herron MJ
Semin Respir Infect; 1986 Jun; 1(2):79-88. PubMed ID: 3317605
[No Abstract] [Full Text] [Related]
6. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
[TBL] [Abstract][Full Text] [Related]
8. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro.
Shindo K; Koide K; Fukumura M
Biochem Biophys Res Commun; 1997 Aug; 237(1):146-51. PubMed ID: 9266847
[TBL] [Abstract][Full Text] [Related]
9. A role for Paf-acether (platelet-activating factor) in acute skin inflammation?
Pirotzky E; Pfister A; Benveniste J
Br J Dermatol; 1985 Jul; 113 Suppl 28():91-4. PubMed ID: 4015984
[No Abstract] [Full Text] [Related]
10. Paf-acether (platelet-activating factor).
Benveniste J
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
[No Abstract] [Full Text] [Related]
11. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
13. The intracellular retention of newly synthesized platelet-activating factor.
Lynch JM; Henson PM
J Immunol; 1986 Oct; 137(8):2653-61. PubMed ID: 3093579
[TBL] [Abstract][Full Text] [Related]
14. The role of lipid mediators in asthma (current views and perspectives).
König W; Schönfeld W; Knöller J; Köller M
Allergol Immunopathol (Madr); 1988; 16(5):289-98. PubMed ID: 3147587
[TBL] [Abstract][Full Text] [Related]
15. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
Breviario F; Bertocchi F; Dejana E; Bussolino F
J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet activating factor in hemodialysis.
Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
von Asmuth EJ; Buurman WA
J Immunol; 1995 Feb; 154(3):1383-90. PubMed ID: 7529802
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
19. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
Stewart AG; Harris T
Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets.
O'Flaherty JT; Salzer WL; Cousart S; McCall CE; Piantadosi C; Surles JR; Hammett MJ; Wykle RL
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):291-309. PubMed ID: 6844746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
